[go: up one dir, main page]

TNSN96021A1 - SUBSTITUTED INDOLES - Google Patents

SUBSTITUTED INDOLES

Info

Publication number
TNSN96021A1
TNSN96021A1 TNTNSN96021A TNSN96021A TNSN96021A1 TN SN96021 A1 TNSN96021 A1 TN SN96021A1 TN TNSN96021 A TNTNSN96021 A TN TNSN96021A TN SN96021 A TNSN96021 A TN SN96021A TN SN96021 A1 TNSN96021 A1 TN SN96021A1
Authority
TN
Tunisia
Prior art keywords
substituted indoles
medicinal products
appropriate
indoles
substituted
Prior art date
Application number
TNTNSN96021A
Other languages
French (fr)
Inventor
Matthias Muller-Gliemann Dr
Ulrich Muller Dr
Martin Beuck Dr
Siegfried Zaiss Dr
Christoph Gerdes Dr
Anke Domdey-Bette Dr
Rudi Grutzmann Dr
Stefan Lohmer Dr
Stefan Wohlfeil Dr
Ozkan Yalkinoglu Dr
James Elting Dr
Dirk Denzer Dr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of TNSN96021A1 publication Critical patent/TNSN96021A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ON PREPARE DES INDOLES SUBSTITUES EN FAISANT REAGIR AVEC DES AMINES APPROPRIEES DES ACIDES CARBOXYLIQUES APPROPRIES, EVENTUELLEMENT EN PRESENCE DE SUBSTANCES AUXILIAIRES. LES INDOLES SUBSTITUES CONVIENNENT COMME PRINCIPES ACTIFS DANS DES MEDICAMENTS, EN PARTICULIER DANS LES MEDICAMENTS DESTINES AU TRAITEMENT DE L'ARTERIOSCLEROSE ET DE LA RESTENOSESUBSTITUTED INDOLES ARE PREPARED BY REACTING WITH APPROPRIATE AMINES OF APPROPRIATE CARBOXYLIC ACIDS, POSSIBLY IN THE PRESENCE OF AUXILIARY SUBSTANCES. SUBSTITUTED INDOLES ARE SUITABLE AS ACTIVE INGREDIENTS IN MEDICINAL PRODUCTS, PARTICULARLY IN MEDICINAL PRODUCTS FOR THE TREATMENT OF ARTERIOSCLEROSIS AND RESTENOSIS

TNTNSN96021A 1995-02-01 1996-02-01 SUBSTITUTED INDOLES TNSN96021A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19503159 1995-02-01
DE19513716A DE19513716A1 (en) 1995-02-01 1995-04-11 Substituted 2-phenylindole derivatives

Publications (1)

Publication Number Publication Date
TNSN96021A1 true TNSN96021A1 (en) 2005-03-15

Family

ID=7752848

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96021A TNSN96021A1 (en) 1995-02-01 1996-02-01 SUBSTITUTED INDOLES

Country Status (10)

Country Link
KR (1) KR960031439A (en)
DE (2) DE19513716A1 (en)
MY (1) MY132270A (en)
RU (1) RU2162842C2 (en)
SG (1) SG38925A1 (en)
SV (1) SV1996000009A (en)
TN (1) TNSN96021A1 (en)
TW (1) TW349092B (en)
YU (1) YU5796A (en)
ZA (1) ZA96726B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517659A1 (en) * 1975-04-22 1976-11-11 Merck Patent Gmbh INDOLDER DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
AU570021B2 (en) * 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
DE3739882A1 (en) * 1987-11-25 1989-06-08 Bayer Ag SUBSTITUTED HYDROXYLAMINE
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides

Also Published As

Publication number Publication date
SG38925A1 (en) 1997-04-17
MY132270A (en) 2007-09-28
TW349092B (en) 1999-01-01
DE59605373D1 (en) 2000-07-13
YU5796A (en) 1999-03-04
SV1996000009A (en) 1996-11-14
RU2162842C2 (en) 2001-02-10
DE19513716A1 (en) 1996-08-08
KR960031439A (en) 1996-09-17
ZA96726B (en) 1996-08-20

Similar Documents

Publication Publication Date Title
TNSN95098A1 (en) DERIVATIVES OF CYCLOALCANOINDOLES AND CYCLOALCANOAZA-INDOLES
TNSN96035A1 (en) N- (3-BENZOFURANNYL) UREA DERIVATIVES
DE69737719D1 (en) SUBSTITUTED GAMMA AMINOBUTTERIC ACID DERIVATIVES AS DRUGS
TR199801180T2 (en) New compounds with analgesic effect.
IS2706B (en) Pharmaceutical composition containing proton pump inhibitor
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
DE69331739D1 (en) INNOVATIVE PHARMACEUTICAL USES OF KRILL ENZYMS
ATE215373T1 (en) 21-HYDRO-6,19-OXIDOPROGESTERONE (21OH-60P) AND THEIR USE AS A MEDICINAL PRODUCT FOR THE TREATMENT OF GLUCOCORTICOID EXCESS
TNSN96007A1 (en) PURINE - 6 - ONES 2.9 - DISUBSTITUTED
TNSN96005A1 (en) 2-(2-n-alcoxyphenyl)-purine-6-ones 9-substituees
DE69632396D1 (en) TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR
IT1276162B1 (en) GERANYLGERANIL DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
DE59610175D1 (en) HYDANTO DERIVATIVES AS INTERMEDIATE PRODUCTS FOR PHARMACEUTICAL ACTIVE SUBSTANCES
HUP9902415A2 (en) Solid instant-release forms of administration and process for producing the same
DE69612056D1 (en) TERPEN DERIVATIVES (SARCODICTYINE) AS AN ANTICRECELLENT
TNSN96021A1 (en) SUBSTITUTED INDOLES
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
TR199801184T2 (en) New compounds with analgesic action.
ATE181324T1 (en) SECO-D STEROIDS ACTIVE IN THE CARDIOVASCULAR SYSTEM AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
ITMI922742A0 (en) COMPOUNDS WITH THERAPEUTIC ACTIVITY USEFUL FOR THE TREATMENT OF DISEASES RELATED TO GLUTATHIONE DEFICIENCY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE232541T1 (en) BALE ACID SALTS WITH PHYSIOLOGICALLY ACTIVE METALS AND THEIR USE FOR THERAPEUTIC TREATMENT
ES2128426T3 (en) WATER SOLUBLE RETINOIDS.
EP0811385A3 (en) Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease
GR3031908T3 (en) Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same